It's true that the fda gets funding from big pharma but that doesn't mean they won't approve covaxin. they might make it hard on the little guy and drag it out so investors get discouraged and sell to cause the stock to drop and that's when they'll start looking at take over strategies
Market Data 
Markets 
AI
